Írsko - angličtina - HPRA (Health Products Regulatory Authority)

a/s alfred benzon - furosemide - capsule - 30 milligram

Írsko - angličtina - HPRA (Health Products Regulatory Authority)

a/s alfred benzon - furosemide - capsule - 60

Írsko - angličtina - HPRA (Health Products Regulatory Authority)

a/s alfred benzon - furosemide - capsule - 120 milligram

Filipíny - angličtina - FDA (Food And Drug Administration)

basic pharmaceutical corp. - furosemide - tablet - 40 mg

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

takeda pharmaceuticals australia pty ltd - nonacog gamma, quantity: 500 iu - injection, powder for - excipient ingredients: histidine; sodium chloride; calcium chloride dihydrate; mannitol; sucrose; polysorbate 80 - 1) routine prophylaxis of bleeding episodes in adults with haemophilia b,2) treatment and prevention of bleeding episodes in adults with haemophilia b (congenital factor ix deficiency),3) peri-operative management in adults with haemophilia b 1) routine prophylaxis of bleeding episodes in patients with haemophilia b 2) treatment and prevention of bleeding episodes in patients with haemophilia b (congenital factor ix deficiency) 3) peri-operative management in patients with haemophilia b

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

takeda pharmaceuticals australia pty ltd - nonacog gamma, quantity: 2000 iu - injection, powder for - excipient ingredients: histidine; sodium chloride; calcium chloride dihydrate; mannitol; sucrose; polysorbate 80 - 1) routine prophylaxis of bleeding episodes in adults with haemophilia b,2) treatment and prevention of bleeding episodes in adults with haemophilia b (congenital factor ix deficiency),3) peri-operative management in adults with haemophilia b 1) routine prophylaxis of bleeding episodes in patients with haemophilia b 2) treatment and prevention of bleeding episodes in patients with haemophilia b (congenital factor ix deficiency) 3) peri-operative management in patients with haemophilia b

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

takeda pharmaceuticals australia pty ltd - nonacog gamma, quantity: 250 iu - injection, powder for - excipient ingredients: histidine; sodium chloride; calcium chloride dihydrate; mannitol; sucrose; polysorbate 80 - 1) routine prophylaxis of bleeding episodes in adults with haemophilia b,2) treatment and prevention of bleeding episodes in adults with haemophilia b (congenital factor ix deficiency),3) peri-operative management in adults with haemophilia b 1) routine prophylaxis of bleeding episodes in patients with haemophilia b 2) treatment and prevention of bleeding episodes in patients with haemophilia b (congenital factor ix deficiency) 3) peri-operative management in patients with haemophilia b

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

takeda pharmaceuticals australia pty ltd - nonacog gamma, quantity: 1000 iu - injection, powder for - excipient ingredients: histidine; sodium chloride; calcium chloride dihydrate; mannitol; sucrose; polysorbate 80 - 1) routine prophylaxis of bleeding episodes in adults with haemophilia b,2) treatment and prevention of bleeding episodes in adults with haemophilia b (congenital factor ix deficiency),3) peri-operative management in adults with haemophilia b 1) routine prophylaxis of bleeding episodes in patients with haemophilia b 2) treatment and prevention of bleeding episodes in patients with haemophilia b (congenital factor ix deficiency) 3) peri-operative management in patients with haemophilia b

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

takeda pharmaceuticals australia pty ltd - nonacog gamma, quantity: 3000 iu - injection, powder for - excipient ingredients: histidine; sodium chloride; calcium chloride dihydrate; mannitol; sucrose; polysorbate 80 - 1) routine prophylaxis of bleeding episodes in patients with haemophilia b 2) treatment and prevention of bleeding episodes in patients with haemophilia b (congenital factor ix deficiency) 3) peri-operative management in patients with haemophilia b

Egypt - angličtina - EDA (Egyptian Drug Authority)

amoun pharmaceutical industries co. - injection - 20 mg/2ml